Biocartis Group NV (EURONEXT:BCART)

European company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - BCART

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - BCART

  • Market Cap€264.150m
  • IndustryHealthcare
  • SectorDiagnostics & Research
  • Currency
  • ISINBE0974281132

Company Profile

Biocartis Group NV is a commercial-stage molecular diagnostics company. It provides diagnostic solutions aimed at improving clinical practice for the patients, clinicians, payers, and industry. The firm has developed an MDx Idylla molecular diagnostic system for oncology and infectious disease segments. Its products include EGFR mutation assay, BRAF mutation test, NRAS mutation test, respiratory panel, etc. The firm derives the majority of its revenues from product sales.Biocartis Group NV along with its subsidiaries develops proprietary molecular diagnostics platform offering molecular information from any biological sample, enabling fast and effective diagnostics treatment selection and treatment progress monitoring.

Latest BCART news

Currently there for this company. Visit our news hub for other news .